By Will Chu, Niamh Michail, Hank Schultz, and Cheryl Tay
The interest in cannabidiol (CBD) use in food supplements, foods, and even as an ingredient in cosmetics has gained much momentum in the past five years, but what is the regulatory situation around the world?
New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
The US Food and Drug Administration took action against 17 companies making illegal Alzheimer’s disease treatment claims. Twelve companies were slapped with warning letters while five received online advisories.
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
A trade association director is calling for better multi-sectoral cooperation in India, to minimise the need for authorities to clamp down on nutraceutical and supplement companies in India for labelling violations.
China’s State Administration for Market Regulation (SAMR) and the Ministry of Commerce summoned all 91 direct-selling firms operating in China to a meeting as part of the “100-day operation” to clean up the health food market.
Faecal microbiota transplantation (FMT) can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows, with the findings leading to a commercialisation agreement.
New Zealand’s natural products sector is facing yet another lengthy process of workshops, surveys and consultations to secure regulations that are fit-for-purpose, after the government signalled its intention to go back to the drawing board.